Efficacy of Novel Non-Chemotherapy Combinations Against AML Cells with Mutant NPM1

被引：0
|
作者：
Mill, Christopher Peter [1 ]
Fiskus, Warren C. [2 ]
Davis, John A. [3 ]
Das, Kaberi [4 ]
Birdwell, Christine E. [3 ]
Kadia, Tapan M. [5 ]
Sasaki, Koji [2 ]
Takahashi, Koichi [2 ]
DiNardo, Courtney D. [2 ]
Loghavi, Sanam [6 ]
Daver, Naval [2 ]
Bhalla, Kapil N. [2 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] UT MD Anderson Canc Ctr, Houston, TX USA
[5] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-169584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5860 / 5861
页数：2
相关论文
共 50 条
  • [1] Efficacy of novel combination therapy against AML cells with mutant NPM1
    Mill, Christopher P.
    Fiskus, Warren C.
    Davis, John A.
    DiNardo, Courtney D.
    Birdwell, Christine
    Jin, Qi
    Takahashi, Koichi
    Khoury, Joseph D.
    Bhalla, Kapil N.
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
    Christopher P. Mill
    Warren Fiskus
    Kaberi Das
    John A. Davis
    Christine E. Birdwell
    Tapan M. Kadia
    Courtney D. DiNardo
    Naval Daver
    Koichi Takahashi
    Koji Sasaki
    Gerard M. McGeehan
    Xinjia Ruan
    Xiaoping Su
    Sanam Loghavi
    Hagop Kantarjian
    Kapil N. Bhalla
    Leukemia, 2023, 37 : 1336 - 1348
  • [3] Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
    Mill, Christopher P.
    Fiskus, Warren
    Das, Kaberi
    Davis, John A.
    Birdwell, Christine E.
    Kadia, Tapan M.
    DiNardo, Courtney D.
    Daver, Naval
    Takahashi, Koichi
    Sasaki, Koji
    McGeehan, Gerard M.
    Ruan, Xinjia
    Su, Xiaoping
    Loghavi, Sanam
    Kantarjian, Hagop
    Bhalla, Kapil N.
    LEUKEMIA, 2023, 37 (06) : 1336 - 1348
  • [4] Development of a novel inhibitor against mutant NPM1
    Oka, Masahiro
    Katoh, Akira
    Akatsuka, Yoshiki
    Kasahara, Yuuya
    Kouji, Hiroyuki
    Kotani, Ai
    CANCER SCIENCE, 2025, 116 : 204 - 204
  • [5] Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
    Warren Fiskus
    Naval Daver
    Steffen Boettcher
    Christopher P. Mill
    Koji Sasaki
    Christine E. Birdwell
    John A. Davis
    Kaberi Das
    Koichi Takahashi
    Tapan M. Kadia
    Courtney D. DiNardo
    Francis Burrows
    Sanam Loghavi
    Joseph D. Khoury
    Benjamin L. Ebert
    Kapil N. Bhalla
    Leukemia, 2022, 36 : 2729 - 2733
  • [6] Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
    Fiskus, Warren
    Daver, Naval
    Boettcher, Steffen
    Mill, Christopher P.
    Sasaki, Koji
    Birdwell, Christine E.
    Davis, John A.
    Das, Kaberi
    Takahashi, Koichi
    Kadia, Tapan M.
    DiNardo, Courtney D.
    Burrows, Francis
    Loghavi, Sanam
    Khoury, Joseph D.
    Ebert, Benjamin L.
    Bhalla, Kapil N.
    LEUKEMIA, 2022, 36 (11) : 2729 - 2733
  • [7] Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation
    Yi, Sha
    Wen, Lu
    He, Jing
    Wang, Youping
    Zhao, Fei
    Zhao, Jie
    Zhao, Zichu
    Cui, Guohui
    Chen, Yan
    ANNALS OF HEMATOLOGY, 2015, 94 (02) : 201 - 210
  • [8] Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation
    Sha Yi
    Lu Wen
    Jing He
    Youping Wang
    Fei Zhao
    Jie Zhao
    Zichu Zhao
    Guohui Cui
    Yan Chen
    Annals of Hematology, 2015, 94 : 201 - 210
  • [9] MUTANT NPM1 MARGINALLY IMPACTS TRANSLATION IN NPM1-MUTATED AML
    Brunetti, L.
    Pianigiani, G.
    Gundry, M.
    Goodell, M.
    Falini, B.
    HAEMATOLOGICA, 2024, 109 : 80 - 80
  • [10] The NPM1 mutant defines AML irrespective of blast count
    Falini, Brunangelo
    Martelli, Maria Paola
    Brunetti, Lorenzo
    Gjertsen, Bjorn T.
    Andresen, Vibeke
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (07) : E187 - E189
12345